# Multimodal imaging in conductive hearing loss: Optimising CT, MRI and CTA for accurate diagnosis and management

**Authors:** Athanasios Vlachodimitropoulos, Michail Athanasopoulos, Afroditi Lepida, Pinelopi Samara, Ioannis E. Papachristos, Theodoros Stathas, Spyridon Lygeros, Georgios Batsaouras

PMC · DOI: 10.4102/sajr.v30i1.3278 · SA Journal of Radiology · 2026-02-12

## TL;DR

This paper reviews how CT, MRI, and CTA imaging can be optimized together to accurately diagnose and manage conductive hearing loss.

## Contribution

The paper provides a structured framework for integrating multimodal imaging to improve diagnostic accuracy in conductive hearing loss.

## Key findings

- High-resolution CT is the gold standard for detecting bony pathologies in CHL.
- MRI is effective for soft tissue contrast and detecting postoperative cholesteatoma.
- CTA is useful for identifying vascular anomalies and aiding surgical planning.

## Abstract

Conductive hearing loss (CHL) results from impaired mechanical transmission of sound through the external or middle ear and is commonly associated with conditions such as otosclerosis, cholesteatoma, ossicular discontinuity, congenital malformations and trauma. Less frequently, it may arise from vascular or neoplastic lesions. Imaging plays a central role in the evaluation of CHL, with high-resolution CT (HRCT) regarded as the gold standard for initial assessment because of its superior spatial resolution in detecting bony pathologies, including fenestral otosclerosis, ossicular chain defects, third-window lesions and trauma-related disruptions. MRI complements HRCT by providing excellent soft tissue contrast, facilitating the detection of postoperative cholesteatoma via non-echo-planar diffusion-weighted imaging and the characterisation of vascular tumours such as glomus tympanicum. CT angiography (CTA), while not routinely indicated, can be valuable for identifying vascular anomalies and aiding surgical planning in selected cases. Technical considerations, such as optimised scan parameters, strategies for radiation dose reduction in paediatric patients and the integration of multiple imaging modalities, are essential for accurate diagnosis and effective treatment planning. Collectively, HRCT, MRI and CTA provide a structured, evidence-based framework for the comprehensive evaluation and management of CHL.

This review synthesises current evidence on HRCT, MRI and CTA in the assessment of CHL, emphasising their complementary roles, protocol optimisation and multimodal integration to enhance diagnostic accuracy and surgical guidance in both paediatric and adult populations.

## Linked entities

- **Diseases:** otosclerosis (MONDO:0005349), cholesteatoma (MONDO:0006530), conductive hearing loss (MONDO:0020679)

## Full-text entities

- **Diseases:** Paget's disease of bone (MESH:D010001), Treacher Collins (MESH:D008342), bony lesions (MESH:D000070896), cholesteatoma (MESH:D002781), effusion (MESH:D000080324), CHL (MESH:D006314), cochlear aplasia (MESH:C536482), sigmoid sinus thrombosis (MESH:D012851), pulsatile tinnitus (MESH:D014012), middle ear tumours (MESH:D004428), aberrant (MESH:D002869), malignancy (MESH:D009369), cochlear-vestibular malformations (MESH:D015834), vascular lesions (MESH:D014652), EAC atresia (MESH:C566245), schwannoma (MESH:D009442), vascular tumours (MESH:D019043), ligamentous avulsion (MESH:D000071562), enlarged vestibular aqueduct syndrome (OMIM:600791), bone erosions (MESH:D014077), retro (MESH:D006261), abscess (MESH:D000038), otitis (MESH:D010031), chronic suppurative otitis media (MESH:D010035), inflammation (MESH:D007249), cochlear nerve aplasia (MESH:D000160), trauma (MESH:D014947), otosclerotic disease (MESH:D004194), ossicular absence and/ (MESH:C537142), CT abnormalities (MESH:D000014), Congenital anomalies (MESH:D000013), Otosclerosis (MESH:D010040), loss (MESH:D016388), fibrosis (MESH:D005355), congenital fusions (MESH:D000069337), SSC (MESH:D000084322), meningioma (MESH:D008579), temporal bone trauma (MESH:D006259), bone fractures (MESH:D050723), sinus tympani disease (MESH:D012852), dehiscence (MESH:D013529), congenital malformations (OMIM:163000), labyrinthitis (MESH:D007762), dysplasias (MESH:D015792), sensorineural hearing loss (MESH:D006319), hearing loss (MESH:D034381), conductive deficit (MESH:D009461), dislocation (MESH:D004204), malformations (MESH:C564254), glomus tympanicum (MESH:D043604), CHARGE syndrome (MESH:D058747), brain abscess (MESH:D001922), labyrinthine fistula (MESH:D005402), meningocele (MESH:D008588), vascular anomalies (MESH:D020785), soft tissue masses (MESH:D017695), Chronic otitis media (MESH:D010033), stapes fixation, absent incus (MESH:C563316), hypoxemia (MESH:D000860), bony atresia of (MESH:D018213)
- **Chemicals:** gadolinium (MESH:D005682)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969493/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12969493/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969493/full.md

---
Source: https://tomesphere.com/paper/PMC12969493